https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/?page=36

Biomedical Research Centre news

Novel therapy reduces disease progression in rare neurodegenerative condition

21 Jun 2018, 11:55 a.m.

A pioneering new treatment trialled at Great Ormond Street Hospital (GOSH) reduces disease progression by 80 per cent for patients with the rare neurological disorder CLN2.

Cannabidiol reduces seizures for children with complex epilepsies

14 Jun 2018, 8:49 p.m.

Cannabidiol, a drug derived from cannabis but with the psychoactive ingredients removed, has been shown to reduce seizures by around 40 % in children with a rare form of drug resistant epilepsy known as Lennox-Gastaut syndrome (LGS).

£1 million award to develop gene therapy for rare blood disorder FHL-2

12 Jun 2018, 9:31 a.m.

Professor Bobby Gaspar is to receive investment of up to £1million from the UCL Technology Fund (UCLTF) to support development of a gene therapy for familial haemophagocytic lymphohistiocytosis (FHL type 2 or ‘FHL-2’) through to a clinical trial.

Marking International Clinical Trials Day at GOSH

28 May 2018, 9:59 p.m.

Earlier this month patients and families at GOSH (Great Ormond Street Hospital) were given the chance to get hands-on with science at our Research Activity Trial and with special lessons in the hospital school.

Ian Simcock - Research Radiographer at GOSH

NIHR Clinical Doctoral Fellowships at GOSH: Class of 2018

15 May 2018, 3:02 p.m.

Three Great Ormond Street Hospital (GOSH) staff members have been awarded National Institute for Health Research (NIHR) Clinical Doctoral Fellowships.